IRIS
PANTANO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.116
NA - Nord America 891
EU - Europa 492
SA - Sud America 15
OC - Oceania 12
AF - Africa 9
Totale 6.535
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 4.248
US - Stati Uniti d'America 851
HK - Hong Kong 427
CN - Cina 343
IT - Italia 138
GB - Regno Unito 125
DE - Germania 68
IN - India 37
NL - Olanda 32
CA - Canada 31
FI - Finlandia 21
CZ - Repubblica Ceca 19
JP - Giappone 19
FR - Francia 14
TR - Turchia 14
AU - Australia 12
BR - Brasile 11
UA - Ucraina 11
AT - Austria 9
EE - Estonia 9
ZA - Sudafrica 9
ID - Indonesia 8
MX - Messico 8
KR - Corea 7
ES - Italia 6
PL - Polonia 5
RU - Federazione Russa 5
SE - Svezia 5
RO - Romania 4
SA - Arabia Saudita 4
BE - Belgio 3
DK - Danimarca 3
GR - Grecia 3
PT - Portogallo 3
BD - Bangladesh 2
CL - Cile 2
LV - Lettonia 2
RS - Serbia 2
AM - Armenia 1
AR - Argentina 1
BY - Bielorussia 1
CH - Svizzera 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KW - Kuwait 1
LT - Lituania 1
MD - Moldavia 1
MS - Montserrat 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
YE - Yemen 1
Totale 6.535
Salva come PNG Salva come JPEG
Città #
Hong Kong 426
Singapore 303
Ashburn 221
Boardman 169
Hefei 167
London 115
Shanghai 113
Los Angeles 40
Rome 34
San Francisco 34
Munich 31
Pune 24
Amsterdam 20
Toronto 20
Brno 18
Council Bluffs 17
Redmond 16
Seattle 16
Santa Clara 15
Washington 14
Helsinki 13
Brooklyn 9
Chicago 9
New York 9
Tokyo 9
Turku 8
Xi'an 8
Boston 7
Canberra 6
Mexico City 6
Montreal 6
São Paulo 6
Hyderabad 5
Melbourne 5
Milan 5
Naples 5
Paris 5
Warsaw 5
Yeonsu-gu 5
Dallas 4
Las Vegas 4
Miami 4
Padova 4
Riyadh 4
Sona 4
Stockholm 4
Vienna 4
West Jordan 4
Ankara 3
Athens 3
Charlotte 3
Copenhagen 3
Durham 3
Johannesburg 3
Manchester 3
Montesilvano Marina 3
Ningbo 3
Oklahoma City 3
Pescara 3
Porto 3
Anyang 2
Beijing 2
Caluire-et-Cuire 2
Falkenstein 2
Ferrara di Monte Baldo 2
Genoa 2
Gragnano 2
Haikou 2
Juneau 2
Karthaus 2
Kragujevac 2
Lyon 2
Madrid 2
Miano 2
Moscow 2
Mumbai 2
Nanjing 2
Oniferi 2
Phoenix 2
Prineville 2
Riga 2
Salt Lake City 2
Scafati 2
Secaucus 2
The Dalles 2
Trieste 2
Wuhan 2
Yuncheng 2
Zhengzhou 2
Agordo 1
Amman 1
Atlanta 1
Bari 1
Berlin 1
Bismarck 1
Brussels 1
Budapest 1
Buffalo 1
Cagliari 1
Campina Grande 1
Totale 2.085
Salva come PNG Salva come JPEG
Nome #
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 215
Abstract 486: MicroRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes 201
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 199
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 193
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 190
Premetastatic niche: ready for new therapeutic interventions? 187
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 187
Designing a broad-spectrum integrative approach for cancer prevention and treatment 186
Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review 183
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 172
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 164
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 161
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 115
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 104
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 102
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 96
Clinical outcomes among major breast cancer subtypes after neoadjuvant chemotherapy: Impact on breast cancer recurrence and survival 92
Anterior and posterior vaginal myomectomy: A new surgical technique 90
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 87
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 87
Preoperative Ultrasound-guided Sub-areolar Biopsy in Predicting Occult Nipple Involvement in Breast Cancer Patients: Proposal for a Methodological Approach 86
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 86
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 85
Biological effects of cabozantinib on bone microenvironment 85
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 85
Subaxillary Replacement Flap Compared with the Round Block Displacement Technique in Oncoplastic Breast Conserving Surgery: Functional Outcomes of a Feasible One Stage Reconstruction 85
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 84
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 83
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 82
Heterogeneous risk profiles among B3 breast lesions of uncertain malignant potential 81
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 81
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 80
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 80
A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twins 79
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 76
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 75
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells. 75
Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge 56
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer 38
Role of c-mesenchymal-epithelial transition pathway in gastric cancer 36
Denosumab for cancer-related bone loss 31
A Nanostring gene expression approach identifies aggressive clinical behavior related genes in dedifferentiated liposarcoma 28
Molecular prognostic factors in patients with pancreatic cancer 28
Neutrophil-to-lymphocyte ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and outcomes with nivolumab in pretreated Non-Small Cell Lung Cancer (NSCLC): a large retrospective multicenter study 27
New targets, new drugs for metastatic bone pain: a new philosophy 26
Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent Mechanisms 26
Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7) 24
The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients 24
Interleukin 1ss-511T gene (IL1ss) polymorphism is correlated with gastric cancer in the Caucasian population: Results from a meta-analysis 23
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan A Phase 2 Single-Arm Clinical Trial 23
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma 23
Effects of cabozantinib on bone turnover markers in real-world metastatic renal cell carcinoma 23
Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: A systematic review and meta-analysis of clinical trials 23
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients 22
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment 22
Bone Health in Cancer Patients 22
TUMORI NEUROENDOCRINI 22
CETUXIMAB: From bench to bedside 22
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives 22
Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in advanced leiomyosarcoma and angiosarcoma 22
Monoclonal antibodies 21
MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients 21
Regression of papillary thyroid cancer during nivolumab for renal cell cancer 21
Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives 21
Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging 21
Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone 21
Targeting bone metastases starting from the preneoplastic niche: home sweet home 20
Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer 20
Olaratumab: PDGFR-alpha inhibition as a novel tool in the treatment of advanced soft tissue sarcomas 20
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients 20
Targeted therapies for bone metastases 20
The role of bone microenvironment, vitamin D and calcium 20
Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions 20
Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey 20
miRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis–associated genes 20
Prognostic and predictive factors in pancreatic cancer 20
Integrin alpha-5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions 20
Change from lung adenocarcinoma to small cell lung cancer as a mechanism of resistance to afatinib 20
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation 20
Osteoporosis 2014 20
S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical models 19
Emerging Therapeutic Targets in Osteoncology 19
New developments of aminobisphosphonates: the double face of Janus 19
Tissue invasion and metastasis: Molecular, biological and clinical perspectives. 19
How do skeletal morbidity rate and special toxicities affect 12-week versus 4-week schedule zoledronic acid efficacy? A systematic review and a meta-analysis of randomized trials 19
Role of glyoxalase-1 in trabectedin-resistant myxoid liposarcoma 19
Targeting bone metastases: New drugs for new targets 19
Effects of cabozantinib on bone turnover markers in patients with metastatic renal cell carcinoma 19
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis 18
Dynamic changes of receptor activator of nuclear factor-κB expression in circulating tumor cells during denosumab predict treatment effectiveness in metastatic breast cancer 18
Molecular predictive factors of response to anti-EGFR antibodies in colorectal cancer patients 18
The Synergistic Effect of Everolimus and Chloroquine on Endothelial Cell Number Reduction Is Paralleled by Increased Apoptosis and Reduced Autophagy Occurrence 18
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 18
Natural history of skeletal disease in primary biliary cancers. National survey on behalf of GICO group (Gruppo Italiano Colangiocarcinoma – Onlus) 18
Cabozantinib affects osteosarcoma growth through a direct effect on tumor cells and modifications in bone microenvironment 17
Facing SARS-CoV-2 outbreak in immunotherapy era 17
Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis Survey 17
Editorial: RANK/RANKL pathway in cancer: Biological activity beyond bone? 17
ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors 17
Dicer and Drosha Expression and Response to Bevacizumab-Based Therapy in Advanced Colorectal Cancer Patients 17
Totale 5.780
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.807
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.807
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022328 0 0 9 1 89 4 8 1 12 1 3 200
2022/202363 2 1 0 1 4 3 7 15 1 3 23 3
2023/2024508 16 49 30 31 50 224 6 20 6 24 16 36
2024/20255.748 76 92 206 49 39 137 115 31 491 456 1.794 2.262
2025/202619 19 0 0 0 0 0 0 0 0 0 0 0
Totale 6.666